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In March 2014 a 20-year-old man was diagnosed with 
cutaneous diphtheria at St. Olavs University Hospital 
in Trondheim, Norway on his return from Africa. The 
man had been in Mozambique since autumn 2013 
and had experienced persistent skin ulcer infections. 
His was in good general health. Toxin-producing 
Corynebacterium diphtheriae was grown from a wound 
specimen. He had completed the national childhood 
vaccination programme and received a diphtheria vac-
cine booster dose in 2005. Screening of close contacts 
revealed an asymptomatic person colonised with non-
toxigenic C. diphtheriae.
Case report and laboratory diagnosis
On 23 March 2014, one week after his arrival from 
Mozambique to Norway, a 20-year-old man presented 
at the Municipal Emergency Department in Trondheim 
with a history of skin ulcer, located on the right big toe 
that had lasted since approximately five to six weeks. 
He had been working in an orphanage in Mozambique 
with three other schoolmates from Norway since 
autumn in the previous year. The patient recalled hav-
ing had similar leg ulcers lasting for several weeks 
from October 2013, acquired after his arrival at the 
orphanage. He could remember some insect bites, as 
well as minor trauma after he had played football in 
open toe sandals during his stay there. These ulcers 
healed after he had received amoxicillin/clavulanic-
acid orally for one week, prescribed by a local physi-
cian in Mozambique.
At the Emergency Department in Trondheim, the exam-
ining physician suspected an infection caused by pyo-
genic bacteria and a wound specimen was requested 
for aerobic culture and screening for meticillin-resistant 
Staphylococcus aureus (MRSA). A treatment consisting 
of oral dicloxacillin tablets 500 mg four times daily was 
initiated.   
After 24 hours of incubation on blood agar and choco-
late agar, abundant growth of almost pure culture of 
small, 1–2 mm in diameter, white, non-haemolytic 
colonies mimicking normal bacterial skin flora, was 
observed. A wet mount demonstrated short rods. 
Using matrix-assisted laser desorption/ionisation 
time-of-flight mass spectrometry (MALDI-TOF MS) on a 
Microflex LT mass spectrometer (Bruker Daltonics) with 
BioTyper 3.2 software database, the isolate was iden-
tified as Corynebacterium diphtheriae. Score values of 
2.113 and 2.041 were interpreted as reliable species 
identification, as recommended by the manufacturer.
On Tinsdale selective medium (Tinsdale agar base: 
Difco product nr.278610 and Tinsdale enrichment 
Difco product nr.234210, BD Diagnostics – Diagnostic 
Systems), the isolate displayed characteristic deep 
brown colonies with halos after 24 hours of incubation. 
Laboratory investigation at the National 
Reference Laboratory
On 26 March the isolate was sent on Amies trans-
port medium to the National Reference Laboratory for 
Diphtheria at the Norwegian Institute of Public Health 
(NIPH), Oslo, and diphtheria toxin tox gene was detected 
by polymerase chain reaction (PCR) [1] on 28 March. 
Diphtheria toxin production was analysed by modified 
Elek test [2] and reported positive on 29 March. The 
strain was identified as C. diphtheriae biotype mitis 
by API Coryne v3 system (BioMérieux, France, code: 
1010364) and supplementary tests (nitrate reduction 
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positive, glycogen fermentation positive, not lipophilic 
and forming large colonies (>1 mm in diameter after 24 
hours of incubation)).
Minimum Inhibitory Concentration (MIC) for benzylpen-
icillin was 0.125 mg/L determined by Epsilometer (E) 
test on a blood agar plate. The European Committee on 
Antimicrobial Susceptibility Testing (EUCAST) have no 
species specific breakpoints for C. diphtheriae, but the 
strain can be categorised as susceptible to benzylpeni-
cillin according the EUCAST recommendations for non-
species related clinical breakpoints [3].
Patient follow-up
After diagnosing C. diphtheriae infection on 25 March, 
and prior to obtaining the results of antimicrobial sus-
ceptibility testing, the treatment was changed from 
dicloxacillin to oral phenoxymethylpenicillin tablets 
660 mg four times daily, according to the suggested 
regimens from The Sandford Guide To Antimicrobial 
Therapy 2014 [4]. The patient vaccination history was 
reviewed; he had completed the national childhood 
vaccination programme and received a diphtheria vac-
cine booster dose in 2005. The next day, on 26 March, 
the patient was admitted to Department of Infectious 
Diseases, St. Olavs Hospital, Trondheim, where he was 
isolated. He was afebrile and in good general health. 
There were no signs of pharyngeal involvement, 
C-reactive protein (CRP) was <5 mg/L (norm: 0–5 mg/L) 
and the leukocyte count was 9.1 x 109/L (norm: 3,7–10 
x 109/L). An ulcerative, non-inflammatory wound was 
observed on his right big toe (Figure). He received 
intravenous benzylpenicillin treatment 1 million IU x 4, 
during the 24 hours hospitalisation and oral phenoxy-
methylpenicillin 660 mg two tablets three times daily 
for two weeks after discharge.
Control measures and contact tracing
Immediately after diagnosing C. diphtheriae infection 
on 25 March, the case was reported by phone to the 
local Medical Officer in the municipality and NIPH in 
accordance with the Communicable Disease Act. In 
collaboration with the treating physician and the local 
Community Medical Officer, contact isolation precau-
tions were implemented until the patient was admit-
ted to the hospital. After discharge, he was isolated in 
his home until two control cultures (throat, nasal and 
wound swab) taken on 9 April and on 10 April and culti-
vated on Tinsdale selective medium, were negative on 
15 April.
Tracing of close contacts was initiated on 25 March 
and oral erythromycin capsules 500 mg two times daily 
for seven days were given prophylactically. A booster 
diphtheria vaccine dose was offered to all contacts who 
received the last diphtheria vaccine dose more than 
five years prior and complete vaccination to those who 
had not been vaccinated in the primary childhood pro-
gramme. Observation of close contacts in their homes 
(for fever, throat pain) in the following seven days after 
they had been exposed to the index patient was rec-
ommended. Throat and nasal specimens were also 
collected from these close contacts, which included 
11 close family members, four friends and the primary 
examining physician. The specimens were cultivated, 
as well as patient control samples, on Tinsdale selec-
tive medium at St. Olavs Hospital, Trondheim; all were 
found negative for C. diphtheriae.
The index patient was attending the boarding school in 
Hurdal (located 70 km north of Oslo) and on his arrival 
to Norway, before he visited his family, the boarding 
school was the accommodation where he spent the 
first week of his vacation. During this week, the index 
patient and other schoolmates had eaten together 
in the kitchen of the boarding school and some of 
them had shared the bathrooms and sleeping rooms. 
Three other schoolmates, who had been working in 
Mozambique at the same time as the index patient, had 
also arrived to the boarding school. Taking this into 
consideration and according information obtained by 
local Medical Community Officer in Hurdal, throat and 
nasal specimens from 53 close contacts: 28 school-
mates and 25 other contacts – employees in the school 
and close contacts out of the boarding school –, were 
collected and sent to Akershus University Hospital in 
Oslo. All samples were cultivated on Tinsdale selective 
agar media (Tinsdale agar base, Oxoid product nr.CM 
0487) and were found negative, except one throat 
swab from one of his schoolmates, a travel companion 
in Mozambique. This isolate was sent to NIPH and iden-
tified as C. diphtheriae biotype mitis by API Coryne v3 
system (BioMérieux, France, code: 1010324) and sup-
plementary tests. The isolate had the same biotype as 
the isolate from the index case, but differed by being 
lactose positive and toxin negative (both with tox gene 
PCR and modified Elek test).
Figure
Ulcerative, non-inflammatory wound on the right big toe 
of a patient with cutaneous diphtheria, Norway, March 
2014
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This schoolmate, who had been working in Mozambique 
at the same orphanage as the index patient, may also 
have been infected during his stay there with another 
strain of C. diphtheriae, the non-toxigenic one, but was 
asymptomatic and discovered by screening. Molecular 
diagnostic that is planned in the near future, the 
genome sequencing of both isolates, should reveal if it 
was the identical strain infected by lysogenic tox phage 
in the index patient or two different strains.
After diagnosing C. diphtheriae throat colonisation, the 
vaccination history of the contact patient was reviewed; 
he had received a booster diphtheria vaccine dose in 
2012 and was not offered a new one. He received the 
oral erythromycin capsules 500 mg two times daily for 
seven days and was isolated in the boarding school 
(separate room and bathroom), until two control throat 
specimens sampled at different times were nega-
tive. The vaccination history of the other 52 persons 
included in screening in Hurdal was reviewed and 29 
close contacts who had been vaccinated more than five 
years prior received a booster diphtheria vaccine dose. 
All close contacts were given the oral erythromycin 
capsules 500 mg two times daily for seven days, with 
some exceptions (one pregnant woman and one child).
One of the schoolmates, who had also been working in 
Mozambique at the same time as others, had noticed 
skin ulcer on his leg, but in his case, the ulcer healed 
spontaneously and at the time of screening, the wound 
swab taken from the scar area was negative for C. 
diphtheriae.
Background and epidemiological situation
Diphtheria is caused by toxigenic strains of C. diph-
theriae, C. ulcerans and C. pseudotuberculosis. It can 
result in an acute bacterial toxic infection of the upper 
respiratory tract or in cutaneous infection, which is 
generally a milder variant of the disease.
Cutaneous diphtheria is usually described as a chronic 
ulcer, often following insect bites or minor trauma. The 
incubation period is on average two to four days for 
respiratory tract diphtheria but is not so well defined 
for cutaneous infection. Immunised persons seldom 
develop systemic toxic manifestations and the slow 
absorption of toxin from skin lesions induces produc-
tion of high antibody levels [5]. Isolation of C. diphthe-
riae by culture may be difficult due to normal throat 
or skin flora and other pathogens present; therefore 
selective media should be employed when diphtheria 
is suspected.
In reports from several European countries [6-9], 
isolates causing cutaneous diphtheria were mainly 
imported and toxigenic. Epidemiological control and 
vaccination are important measures in reducing the 
possibility of establishment of a reservoir for second-
ary transmission of both cutaneous and respiratory 
diphtheria [10].
Diphtheria is rarely diagnosed in Norway due to high 
vaccine coverage. During the period from 1975 to 2013 
only five cases of throat diphtheria or colonisation 
have been reported to the Norwegian Surveillance 
System for Communicable diseases (MSIS). In 1992, a 
young man from the county of Finnmark was infected 
after contact with a person from Russia. In 2008, a 
mother and her child were diagnosed with throat diph-
theria after visiting Latvia. After their return to Norway, 
the father and one other child were infected [11,12].
A brief report of the present case has been covered in 
the bulletins of NIPH on 2 April 2014 as the first diag-
nosed toxigenic cutaneous diphtheria in Norway [13].      
Discussion
Cutaneous diphtheria is endemic in some eastern 
European countries (Latvia, Russia) and many parts 
of the world (Brazil, Eastern Mediterranean region, 
Haiti, the Indian subcontinent, Indonesia, Nigeria and 
Philippines) [5] and physicians should be aware of the 
possibility of diphtheria in patients returning from vis-
its/travel in endemic areas. C. diphtheriae can survive 
up to three months in floor dust [14] and in endemic 
areas with tropical climate this can be a likely source 
of infection/transmission.   
The report illustrates the importance of diagnosing 
diphtheria cases as soon as possible, given the amount 
of resources needed for subsequent contact-tracing 
and control measures, which is likely to increase when 
detection of an initial case is delayed. 
The diagnosis of diphtheria in the present case empha-
sises the importance of detailed clinical and epidemio-
logical information given by the examining physician as 
well as access to modern diagnostic modalities. MALDI-
TOF MS is easy to use, cost effective and enables rapid 
species identification in a couple of minutes [15]. The 
usefulness of MALDI-TOF MS as a tool for reliable C. 
diphtheriae identification was recently investigated by 
Konrad et al. [16]. They correctly identified to the spe-
cies level all 90 potentially toxigenic Corynebacterium 
strains and proposed an algorithm for fast and reliable 
identification of C. diphtheriae incorporating MALDI-
TOF MS, real-time tox PCR and Elek testing. This work-
flow was shown to be both rapid and effective in our 
case.   
The participation of laboratory in Trondheim in the 
United Kingdom National External Quality Assessment 
Service for Microbiology (UK NEQAS) also proved ben-
eficial. One isolate of toxin-negative C. diphtheriae was 
recently distributed by UK NEQAS on 3 February 2014 
(distribution nr.3361), and was successfully identified 
by MALDI TOF MS.
The collaboration of the laboratory in Trondheim with 
NIPH, performing the tox gene PCR, Elek testing, bio-
typing and susceptibility testing, and with the local 
Community Medical Officer, proved very efficient and 
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optimal in the present case, when encountering a rare 
and potentially severe infectious disease. The contact 
patient diagnosed with non-toxigenic C. diphtheriae 
remained asymptomatic. Non-toxigenic strains of C. 
diphtheriae are recently recognised as emerging path-
ogens across Europe [17]. Such strains, however, can 
convert to toxigenicity by infection with lysogenic tox 
phage [18,19]. The circulation of resident non-toxigenic 
strains in the community thus can represent an ongo-
ing risk by conversion to highly virulent strains follow-
ing lysogenisation.           
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